Clearbridge Health Ltd. · SGX:1H3
Clearbridge Health — FY2018 Earnings Presentation
39 slides from Clearbridge Health's earnings presentation, Mar 6, 2019
Slide 1: Corporate Presentation 4Q and Full Year 2018
Corporate Presentation 4Q and Full Year 2018
Slide 2: Important notice
Important Clearbridge Health Limited is a company listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). notice This presentation has been prepared by the Company and its contents have been reviewed by the Company’s sponsor, United Overseas Bank Limited (th
Slide 3: Building the First Precision Medicine Platform in Asia
What is Precision Medicine? Why the Focus on Precision Medicine? Building the Precision An approach for disease treatment and prevention that According to a new market intelligence report by BIS Research, titled "Global Precision Medicine Market- First Precision Medicine takes into account individua
Slide 4: Our Value Creation Process
• Capitalising valuation multiple differential between public and private market Our Value Unlocking • Healthcare EV/EBITDA: 10.5x – 56x Creation Value • P/ EBITDA of key potential targets range from 3 – 12x Process • Maximising revenue growth by achieving economies of scope (new precision medicine
Slide 5: Enabling Better Healthcare and Treatment
Enabling Better With individual genomic profile Genomic & metabolomic driven tests Healthcare and • • Implement 5, 10 year health monitoring programs Dietary management • Health screening Treatment • GPs and dental • Aesthetics Lifestyle & Primary • Dialysis Via an ecosystem of Wellness Healthcare •
Slide 6: One of the First Players in Asia
One of the First Players Philippines - Clearbridge Medical Philippines, a Hong Kong - Medical clinic in Causeway Bay in Asia medical center in Manila - Distribution network of diagnostic - Distribution network of services diagnostic services With a diversified - ClearSkin, a derma clinic chain regio
Slide 7: Significant Opportunities for 3rd Party Collaborations
Significant Screening & Diagnosis Opportunities for 3rd Party Collaborations Tapping on a network of technology With our diversified Treatment Selection and clinical partners to: product & services portfolio in Asia • Enhance product and service offerings • Gain access to cutting edge R&D activities
Slide 8: Exponential Growth Revenue of Acquired Businesses
PT Tirta Medika Jaya (TMJ) Revenue By Quarter (S$’000) • Acquired 55% effective stake in end April 2018 2,500 • Co-operate renal dialysis facilities with 21 hospitals throughout Exponential 2,052 2,250 Indonesia • Valuation: S$10.0m (10x of forward-looking EBITDA of S$1.0m) Growth 2,000 415 400 • EB
Slide 9: Key P&L Highlights
Key P&L Revenue Q1 FY2018 Q2 FY2018 Q3 FY2018 Q4 FY2018 FY2018 FY2017 Highlights Revenue 377 1,456 2,052 2,250 6,135 288 Higher expenses in Key Expenses Q1 FY2018 Q2 FY2018 Q3 FY2018 Q4 FY2018 FY2018 FY2017 line with strong Employee benefits 1,159 1,619 1,486 3,151 7,415 3,499 revenue growth expense
Slide 10: Key P&L Highlights
Key P&L Q1 Q2 Q3 Q4 FY2018 FY2017 FY2018 FY2018 FY2018 FY2018 Highlights Loss before taxation (1,674) (12,159) (2,417) (2,477) (18,727) (10,906) Adjusted EBITDAR Loss attributable to owners (1,489) (12,230) (2,505) (2,224) (18,448) (7,470) of the company Adjusted for following items: Fair value loss
Slide 11: Key Balance Sheet Highlights
Key Balance S$’000 As at As at 31 Dec 2018 31 Dec 2017 Sheet Cash and bank balances 8,005 27,740 Highlights Total assets 62,762 68,793 Asset light with low debt Borrowings (current) 470 9 Borrowings (non-current) 2,419 1,632 Total liabilities 15,232 9,150 Net debt / Total equity 6.08% 2.75% 11
Slide 12: Key Milestones Achieved Since IPO
Key Milestones Achieved Since IPO Jan 18 Apr 18 Partnership with Jul 18 Partnership with Dec 17 MILS distributorship A Star’s GIS Agen Lab IPO Became an exclusive Partnered with Genome Exclusive partnership Dec 18 IPO on SGX- distributor for MILS Institute of Singapore (GIS) with Agen Lab to IPO of
Slide 13: Our Near-Term Focus
Our Near- 1 Primary and secondary 2 Healthcare systems 3 Investments in medical technology healthcare services companies Term Focus • Build a compelling aesthetics • Become a leading regional • Biolidics – (i) achieve lab developed business catering to all laboratory testing services tests commercia
Slide 14: Our Investment Merits
Our 1 Direct proxy to the defensive and high-growth healthcare industry in Asia Investment Merits 2 Global trend of precision medicine underpins the industry’s strong prospects and market potential in Asia A Fast-Growing 3 Differentiated business strategy by building the first precision medicine pla
Slide 15: Q&A
Q&A 15
Slide 16: Thank you
Thank you 16
Slide 17: Appendix
Appendix 17
Slide 18: Experienced Management Team
Experienced Management Team Jeremy Yee With proven track • Former CEO - Cordlife Group Limited (SGX-listed) Executive Director records in Asia’s • Former CFO - Cordlife Limited and CEO • M.Comm (University of Sydney), MBA (Chicago Booth), healthcare industry M.A (Columbia University) Simon Hoo Dr. L
Slide 19: Dedicated and Experienced Market Team Across Asia
Dedicated and Indonesia Philippines Malaysia Experienced Adrian Chu Dr. Rainer Mozo Dr. Ng Ee Vern Market Sr. Regional Medical Director Medical Director Business Development Dev. Director (Philippines) (Malaysia) Team Across • Former COO of Acepio Pte Ltd – ERP solutions • Fellow, Philippine College
Slide 20: Regional Updates
Regional Updates 20
Slide 21: Singapore
Singapore 21
Slide 22: Sam Laboratory
Sam Laboratory • Moved into our new premise in March 2018. • Acquired Cobas® 6000 analyzer following the introduction of a new hormone test. 22
Slide 23: Philippines
Philippines 23
Slide 24: Clearbridge Medical Group Philippines
Clearbridge • Renovation completed February 2019. Medical Group Philippines • Improved facilities to offer comprehensive range of (CMP) diagnostic and medical services. Rebranding of Marzan Health Care • Pending the approval for the accreditation by the Department of Health as an approved Overseas F
Slide 25: Clearbridge Medical Group Philippines
Clearbridge • Dedicated Corporate Wellness Clinic for Pre- Medical Group Employment and Annual Philippines Physical Exam of private and government Multispecialty accounts. Clinics (MSC) & Corporate Wellness • Multi-specialty clinics Clinic (CWC) offers one convenient location for major types of prim
Slide 26: Clearbridge Medical Group Philippines Dialysis Center
Clearbridge Medical Group Philippines Dialysis Center 26
Slide 27: Clearbridge Medical Group Philippines Mobile Clinic
Clearbridge • Newly revamp mobile clinic Medical Group equipped with Philippines Digital X-ray to cater to on-site Mobile Clinic annual check-ups for corporate accounts. 27
Slide 28: Clearbridge Medical Group Philippines ClearSMILE
Clearbridge Medical Group Philippines ClearSMILE Advanced Dental Care and Diagnostics Cone Beam CT Scan Pediatric & Adult/Ortho Dentistry 28
Slide 29: ClearSkin Advanced Dermatology
ClearSkin 3 branches • Quezon City, Advanced Metropolitian Manila Dermatology • Valenzuela City & (currently under renovation) & Laser • Lapulapu City, Cebu Center, Philippines First hospital-based skincare and Lapulapu City , Cebu aesthetic centre. 29
Slide 30: Clearbridge Medical Group Philippines Pharmacy
Clearbridge • In partnership with the Department Social Medical Group Welfare and Development (DSWD), CMP pharmacies are serving over 2,000 State- Philippines sponsored Filipinos from different government Pharmacy hospitals and agencies. Manila Branch & • Serving 21 government hospitals through Quez
Slide 31: Hong Kong
Hong Kong 31
Slide 32: Clearbridge Medical, Hong Kong
Clearbridge • Rapid growth in 2018 with Medical, monthly patient volume > 350. • Significant revenue growth Hong Kong YoY. Clinic • Further diversified product and service portfolio. • Expanded collaboration with new local and Chinese business partners. • New clinic expansion plan in Clinic will be
Slide 33: Malaysia
Malaysia es 33
Slide 34: Clearbridge Medica, Malaysia
Clearbridge Medica, Malaysia • Completed renovation works Plaza Arkadia, January 2019. Desa Parkcity • Awaiting final clearance from MOH for licensing. 34
Slide 35: Clearbridge Medica, Malaysia Partnerships
Clearbridge 12 GP clinics in Klang Valley, KL Medica, Malaysia Partnerships 6 branches in Klang Valley have been shortlisted to be the outlet to provide • Hereditary Cancer Gene Test • RightMed 35
Slide 36: Indonesia
Indonesia 36
Slide 37: PT Tirta Medika Jaya (TMJ) – Hemodialysis Treatment
PT Tirta RSUD Dr Soehadi Projonegoro 21 hospitals to date Medika Jaya RSUD Kumpulan Pane RSUD Dustira (TMJ) – RSUD Bayu Asih Indonesia RSUD Ciamis Hemodialysis RSUD Djasamen Saragih Treatment RS Sari Mutiara RS Pring Sewu and more … Before After 37
Slide 38: PT Tirta Medika Jaya (TMJ) – Indonesia footprint
PT Tirta Medika Jaya (TMJ) – Indonesia TMJ Footprint 2018 (current hospitals) Future Targets (untapped regions) 38
Slide 39: Thank you
Thank you £4)